Glossary · regenerative medicine A–Z

Umbilical-Cord Cells

An imprecise label for cell preparations derived from cord blood or tissue; source, identity and processing must be specified.

Why Umbilical-Cord Cells matters when choosing treatment

Cells harvested from umbilical-cord blood or tissue (Wharton's jelly, amnion) immediately after delivery—a one-time source of stem and immune cells. They're young, expand vigorously in culture, and are being studied for immune disorders, inflammatory conditions, and neurological injury. Clinics favour cord cells because they're non-invasive to collect and less immunogenic than adult cells. When evaluating clinics, ask about viability post-thaw (cord cells stored for years may have degraded) and whether the clinic tests for infectious agents comprehensively. Also clarify whether they're using fresh cord cells or centuries-old cryopreserved samples.

Related terms & context

Sources & further reading

← All terms · Conditions compared →

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information